Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a Community

NCT07502703 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-04-20

No results posted yet for this study

Summary

The goal of this observational study is to evaluate whether a contactless camera-based technology, called remote photoplethysmography (rPPG), can accurately measure cardiovascular parameters and estimate cardiovascular risk in adults aged 30 years and older living in a community setting in Semanan, Jakarta. This study aims to determine if rPPG can be used as a simple and accessible tool for early cardiovascular screening.

The main questions it aims to answer are:

1. Do cardiovascular parameters measured using rPPG (such as blood pressure, heart rate, and cardiac workload) agree with standard clinical measurements?
2. Do cardiovascular risk estimates generated by rPPG (such as ASCVD risk and Framingham heart age) correspond to risk calculations obtained using conventional clinical and laboratory methods?

Researchers will compare results obtained from rPPG-based facial video scans with results from standard medical assessments, including blood pressure measurements, heart rate evaluation, and laboratory tests for cholesterol levels, to determine the level of agreement and accuracy.

Participants will:

1. Undergo a short facial video scan (approximately 30-60 seconds) using an rPPG-based system
2. Receive standard clinical assessments, including blood pressure and heart rate measurements
3. Provide basic health information (such as age, sex, smoking status, and treatment history) Undergo simple laboratory testing for cholesterol levels

This study is expected to help determine whether rPPG can be used as a reliable, non-invasive, and scalable screening tool for cardiovascular risk in community and primary healthcare settings.

Conditions

Sponsors & Collaborators

  • Tarumanagara University

    lead OTHER

Principal Investigators

  • Ernawati Ernawati · Universitas Tarumanagara

  • Yohanes Firmansyah · Universitas Tarumanagara

  • Alexander Halim Santoso · Universitas Tarumanagara

  • David Wongso · DexWellness

  • Ratheesh Nair · Watch Your Health

  • Sri Tiarti · Universitas Tarumanagara

  • Noer Saelan Tadjudin · Universitas Tarumanagara

  • Clement Drew · Universitas Tarumanagara

  • Zita Atzmardina · Universitas Tarumanagara

  • Andria Priyana · Universitas Tarumanagara

  • Putu Tommy Yudha Sumatera Suyasa · Universitas Tarumanagara

  • Kieren Nathan Wong · Monash University

  • Jaydee Kirani Wong · Melbourne University

  • Meiske Yunithree Suparman · Universitas Tarumanagara

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-23
Primary Completion
2026-06-30
Completion
2026-12-30

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07502703 on ClinicalTrials.gov